LISATA THERAPEUTICS, INC.: 10-Q filed 2017-11-09

Name: LISATA THERAPEUTICS, INC.: 10-Q filed 2017-11-09
Creator: LISATA THERAPEUTICS, INC.

What LISATA THERAPEUTICS, INC. reported in its quarterly report filed 2017-11-09 (fiscal Q3 2017): 36 published measures, 100 facts as tagged in accession 0000320017-17-000093.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-11-09
Fiscal period: fiscal Q3 2017
Accession: 0000320017-17-000093 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All LISATA THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-09-30	67,555,259	USD
At 2016-12-31	53,514,442	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-09-30	14,574,932	USD
At 2016-12-31	30,047,962	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-09-30	53,332,710	USD
At 2016-12-31	4,883,909	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2017-09-30	15,077,872	USD
At 2016-12-31	7,076,651	USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	-16,906,232	USD	273
2016-01-01 to 2016-09-30	-20,292,231	USD	274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	118,478	USD	273
2016-01-01 to 2016-09-30	1,068,130	USD	274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	-754,446	USD	273
2016-01-01 to 2016-09-30	20,896,315	USD	274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	23,036,191	USD	273
2016-01-01 to 2016-09-30	-2,315,753	USD	274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-09-30	-378,947,243	USD
At 2016-12-31	-404,788,809	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-2,413,951	USD	92
2017-01-01 to 2017-09-30	-8,301,494	USD	273
2016-07-01 to 2016-09-30	0	USD	92
2016-01-01 to 2016-09-30	0	USD	274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-09-30	364,118	USD
At 2016-12-31	705,438	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-6,129,901	USD	92
2017-01-01 to 2017-09-30	-20,272,745	USD	273
2016-07-01 to 2016-09-30	-5,727,520	USD	92
2016-01-01 to 2016-09-30	-24,009,615	USD	274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-09-30	65,773,702	USD
At 2016-12-31	24,648,961	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	8,687	USD	92
2017-01-01 to 2017-09-30	372,099	USD	273
2016-07-01 to 2016-09-30	368,364	USD	92
2016-01-01 to 2016-09-30	1,601,421	USD	274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-09-30	11,374,778	USD
At 2016-12-31	21,182,893	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2017-09-30	879,625	USD
At 2016-12-31	2,226,580	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2017-09-30	401,558	USD
At 2016-12-31	138,774	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	6,129,901	USD	92
2017-01-01 to 2017-09-30	20,272,745	USD	273
2016-07-01 to 2016-09-30	5,727,520	USD	92
2016-01-01 to 2016-09-30	24,009,615	USD	274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	2,942,877	USD	92
2017-01-01 to 2017-09-30	9,081,806	USD	273
2016-07-01 to 2016-09-30	2,768,927	USD	92
2016-01-01 to 2016-09-30	10,513,570	USD	274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	3,187,024	USD	92
2017-01-01 to 2017-09-30	11,190,939	USD	273
2016-07-01 to 2016-09-30	2,958,593	USD	92
2016-01-01 to 2016-09-30	13,496,045	USD	274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-09-30	9,427,001	shares
At 2016-12-31	8,205,791	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2017-09-30	20,080,521	USD
At 2016-12-31	7,076,651	USD
At 2016-09-30	11,644,065	USD
At 2015-12-31	18,657,971	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-09-30	433,006,780	USD
At 2016-12-31	410,372,049	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2017-09-30	-28,717	USD
At 2016-12-31	0	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2017-09-30	52,980,327	USD
At 2016-12-31	4,066,480	USD
At 2016-09-30	9,989,495	USD
At 2015-12-31	23,283,824	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2017-09-30	1,417,439	USD
At 2016-12-31	1,582,209	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2017-09-30	3,200,154	USD
At 2016-12-31	389,858	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2017-09-30	10,135,600	USD
At 2016-12-31	2,659,433	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2017-09-30	920,008	USD
At 2016-12-31	1,900,493	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-5,961,733	USD	92
2017-01-01 to 2017-09-30	-20,507,556	USD	273
2016-07-01 to 2016-09-30	-6,090,767	USD	92
2016-01-01 to 2016-09-30	-25,591,477	USD	274

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-3,547,782	USD	92
2017-01-01 to 2017-09-30	25,123,901	USD	273
2016-07-01 to 2016-09-30	-7,287,605	USD	92
2016-01-01 to 2016-09-30	-27,220,171	USD	274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-3,457,157	USD	92
2017-01-01 to 2017-09-30	25,812,849	USD	273
2016-07-01 to 2016-09-30	-6,883,019	USD	92
2016-01-01 to 2016-09-30	-26,698,652	USD	274

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-3,428,440	USD	92
2017-01-01 to 2017-09-30	25,841,566	USD	273
2016-07-01 to 2016-09-30	-6,882,533	USD	92
2016-01-01 to 2016-09-30	-26,698,166	USD	274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	176,855	USD	92
2017-01-01 to 2017-09-30	137,288	USD	273
2016-07-01 to 2016-09-30	5,117	USD	92
2016-01-01 to 2016-09-30	19,559	USD	274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	168,168	USD	92
2017-01-01 to 2017-09-30	-234,811	USD	273
2016-07-01 to 2016-09-30	-363,247	USD	92
2016-01-01 to 2016-09-30	-1,581,862	USD	274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	262,784	USD	273
2016-01-01 to 2016-09-30	-14,424	USD	274

Inspect the source

Entity: LISATA THERAPEUTICS, INC. / CIK 0000320017
Captured: 2026-09-19T14:56:51.274Z
SEC response SHA-256: cea21c045f03a86f28b8ca2c2ed8647182755ec7b9afe40200702f5307c095db

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000320017.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))